NCT02820298View on ClinicalTrials.gov

Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 20, 2016

Primary Completion Date

August 29, 2016

Study Completion Date

August 29, 2016

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Bexagliflozin

Bexagliflozin tablet, 20 mg

Trial Locations (1)

80228

Denver Clinical Research Unit, Lakewood

Sponsors

Lead Sponsor

Theracos
All Listed Sponsors
lead

Theracos

INDUSTRY

NCT02820298 - Study to Evaluate the Effects of a High-Fat Meal on Bexagliflozin in Healthy Subjects | Biotech Hunter | Biotech Hunter